Skip to main content
Erschienen in: Journal of Public Health 2/2020

18.03.2019 | Review Article

The regular consumption of coffee and development of type 2 diabetes mellitus

verfasst von: Muneera Q. Al-Mssallem

Erschienen in: Journal of Public Health | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Drinking coffee is habitually widespread around the world. Moderate coffee consumption has a beneficial health effect on the human body. However, there are controversial effects of consuming coffee on blood glucose and insulin levels in diabetic patients, which remain to be fully elucidated.

Purpose

The aim of this review was to clarify the relationship between coffee consumption and developing type 2 diabetes mellitus (T2DM).

Methods

The common internet search engines were utilized to access the abstracts and full text of articles published in English in the last 20 years.

Results

The association between the frequent consumption of coffee and the risk of developing type 2 diabetes has been studied intensively through epidemiologic and intervention studies. In fact, coffee is a major source of chlorogenic acids (CGAs) in the human diet. The presence of CGAs and other phenolic compounds in coffee plays a role in inhibiting glucose absorption via interference with glucose transporters and increasing insulin sensitivity. However, short-term trials confirmed the detrimental effects of heavily drinking coffee due to the presence of caffeine. Caffeine has been found to impair glucose tolerance and decrease insulin sensitivity.

Conclusion

Several clinical trials have confirmed the relationship between the consumption of coffee and the development of T2DM. Moderate consumption of coffee has been suggested for its long-term benefits and positive health effects.
Literatur
Zurück zum Zitat Al-Mssallem MQ, Brown JE (2013) Arabic coffee increases the glycemic index but not insulinemic index of dates. Saudi Med J 34:923–928PubMed Al-Mssallem MQ, Brown JE (2013) Arabic coffee increases the glycemic index but not insulinemic index of dates. Saudi Med J 34:923–928PubMed
Zurück zum Zitat American Diabetes Association (ADA) (2009) Standards of medical care in diabetes—2009. Diabetes Care 32(Suppl 1):S13–S61CrossRef American Diabetes Association (ADA) (2009) Standards of medical care in diabetes—2009. Diabetes Care 32(Suppl 1):S13–S61CrossRef
Zurück zum Zitat American Diabetes Association (ADA) (2012) In: Burant CF, Young LA (eds) Medical management of type 2 diabetes, 7th edn. ADA, Alexandria, VA American Diabetes Association (ADA) (2012) In: Burant CF, Young LA (eds) Medical management of type 2 diabetes, 7th edn. ADA, Alexandria, VA
Zurück zum Zitat American Diabetes Association (ADA) (2018) Standards of medical care in diabetes—2018. Diabetes Care 41(Suppl 1):S1–S2 American Diabetes Association (ADA) (2018) Standards of medical care in diabetes—2018. Diabetes Care 41(Suppl 1):S1–S2
Zurück zum Zitat Cai L, Ma D, Zhang Y, Liu Z, Wang P (2012) The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 66:872–877CrossRef Cai L, Ma D, Zhang Y, Liu Z, Wang P (2012) The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 66:872–877CrossRef
Zurück zum Zitat del Castillo MD, Ames JM, Gordon MH (2002) Effect of roasting on the antioxidant activity of coffee brews. J Agric Food Chem 50(13):3698–3703CrossRef del Castillo MD, Ames JM, Gordon MH (2002) Effect of roasting on the antioxidant activity of coffee brews. J Agric Food Chem 50(13):3698–3703CrossRef
Zurück zum Zitat Egger G, Cameron-Smith D, Stanton R (1999) The effectiveness of popular, non-prescription weight loss supplements. Med J Aust 171:604–608CrossRef Egger G, Cameron-Smith D, Stanton R (1999) The effectiveness of popular, non-prescription weight loss supplements. Med J Aust 171:604–608CrossRef
Zurück zum Zitat Farah A (2012) Coffee constituents. In: Chu Y-F (ed) Coffee: emerging health effects and disease prevention, 1st edn. John Wiley & Sons, Inc. and Blackwell Publishing Ltd., New York Farah A (2012) Coffee constituents. In: Chu Y-F (ed) Coffee: emerging health effects and disease prevention, 1st edn. John Wiley & Sons, Inc. and Blackwell Publishing Ltd., New York
Zurück zum Zitat Garrett R, Vaz BG, Hovell AMC, Eberlin MN, Rezende CM (2012) Arabica and Robusta coffees: identification of major polar compounds and quantification of blends by direct-infusion electrospray ionization–mass spectrometry. J Agric Food Chem 60:4253–4258. https://doi.org/10.1021/jf300388m CrossRefPubMed Garrett R, Vaz BG, Hovell AMC, Eberlin MN, Rezende CM (2012) Arabica and Robusta coffees: identification of major polar compounds and quantification of blends by direct-infusion electrospray ionization–mass spectrometry. J Agric Food Chem 60:4253–4258. https://​doi.​org/​10.​1021/​jf300388m CrossRefPubMed
Zurück zum Zitat Horton TJ, Geissler CA (1996) Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women. Int J Obes Relat Metab Disord 20:91–97PubMed Horton TJ, Geissler CA (1996) Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women. Int J Obes Relat Metab Disord 20:91–97PubMed
Zurück zum Zitat Louie JC, Atkinson F, Petocz P, Brand-Miller JC (2008) Delayed effects of coffee, tea and sucrose on postprandial glycemia in lean, young, healthy adults. Asia Pac J Clin Nutr 17:657–662PubMed Louie JC, Atkinson F, Petocz P, Brand-Miller JC (2008) Delayed effects of coffee, tea and sucrose on postprandial glycemia in lean, young, healthy adults. Asia Pac J Clin Nutr 17:657–662PubMed
Zurück zum Zitat McCusker RR, Goldberger BA, Cone EJ (2003) Caffeine content of specialty coffees. J Anal Toxicol 27:520–522CrossRef McCusker RR, Goldberger BA, Cone EJ (2003) Caffeine content of specialty coffees. J Anal Toxicol 27:520–522CrossRef
Zurück zum Zitat Oka K (2007) Pharmacological bases of coffee nutrients for diabetes prevention. J Pharm Soc Japan 127:1825–1836CrossRef Oka K (2007) Pharmacological bases of coffee nutrients for diabetes prevention. J Pharm Soc Japan 127:1825–1836CrossRef
Zurück zum Zitat Olefsky JM, Kruszynska YT (2001) Type 2 diabetes mellitus: etiology, pathogenesis, and natural history. In: Endocrinology, 4th edn. WB Saunders. Philadelphia, pp 776–797 Olefsky JM, Kruszynska YT (2001) Type 2 diabetes mellitus: etiology, pathogenesis, and natural history. In: Endocrinology, 4th edn. WB Saunders. Philadelphia, pp 776–797
Zurück zum Zitat Stalmach A, Mullen W, Barron D, Uchida K, Yokota T, Cavin C, Steiling H, Williamson G, Crozier A (2009) Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab Dispos 37:1749–1758. https://doi.org/10.1124/dmd.109.028019 CrossRefPubMed Stalmach A, Mullen W, Barron D, Uchida K, Yokota T, Cavin C, Steiling H, Williamson G, Crozier A (2009) Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab Dispos 37:1749–1758. https://​doi.​org/​10.​1124/​dmd.​109.​028019 CrossRefPubMed
Metadaten
Titel
The regular consumption of coffee and development of type 2 diabetes mellitus
verfasst von
Muneera Q. Al-Mssallem
Publikationsdatum
18.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Public Health / Ausgabe 2/2020
Print ISSN: 2198-1833
Elektronische ISSN: 1613-2238
DOI
https://doi.org/10.1007/s10389-019-01055-7

Weitere Artikel der Ausgabe 2/2020

Journal of Public Health 2/2020 Zur Ausgabe